Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection.

Slides:



Advertisements
Similar presentations
Volume 72, Issue 3, Pages (September 2017)
Advertisements

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer  Marco Bandini, Giorgio Gandaglia, Nicola Fossati, Francesco.
Volume 61, Issue 3, Pages (March 2012)
Erectile Function Recovery After Nerve-Sparing Radical Prostatectomy for Prostate Cancer: Is Back to Baseline Status Enough for Patient Satisfaction? 
Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate.
Volume 71, Issue 6, Pages (June 2017)
Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for.
Testosterone Therapy in Men With Prostate Cancer
Volume 72, Issue 6, Pages (December 2017)
Prostate Cancer 2008: Challenges in Diagnosis and Management
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer  Francesco Cantiello, Giorgio.
Volume 67, Issue 3, Pages (March 2015)
Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database 
European Urology Oncology
Volume 73, Issue 3, Pages (March 2018)
European Urology Oncology
Volume 61, Issue 3, Pages (March 2012)
Volume 53, Issue 5, Pages (May 2008)
Volume 68, Issue 5, Pages (November 2015)
Volume 67, Issue 2, Pages (February 2015)
European Urology Oncology
Towards Early and More Specific Diagnosis of Prostate Cancer
Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal.
Prostate Cancer Detection: A View of the Future
Volume 199, Issue 4, Pages e768-e769 (April 2018)
Volume 62, Issue 6, Pages (December 2012)
Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions  Anwar R. Padhani, Jeffrey Weinreb, Andrew.
Luis Martínez-Piñeiro  European Urology Supplements 
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
Volume 70, Issue 6, Pages (December 2016)
Volume 65, Issue 6, Pages (June 2014)
Tillmann Loch, Pat Fox Fulgham  European Urology 
Volume 68, Issue 4, Pages (October 2015)
Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer  Valeria.
Volume 67, Issue 6, Pages (June 2015)
Volume 65, Issue 4, Pages (April 2014)
Volume 68, Issue 6, Pages (December 2015)
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
Prostate-Specific Antigen, Digital Rectal Examination, and Transrectal Ultrasonography: Their Roles in Diagnosing Early Prostate Cancer  MICHAEL R. CUPP,
European Urology Oncology
European Urology Oncology
Biopsy of the Vesico-Urethral Anastomosis after Radical Prostatectomy: When and How  Vincenzo Scattoni, Marco Roscigno, Marco Raber, Paolo Consonni, Luigi.
Prostate Cancer Nomograms: An Update
Volume 50, Issue 4, Pages (October 2006)
Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of.
European Urology Oncology
Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer  Felix Preisser, Michele Marchioni, Sebastiano.
European Urology Oncology
European Urology Oncology
Volume 65, Issue 3, Pages (March 2014)
European Urology is “Your” Journal
Volume 75, Issue 4, Pages (April 2019)
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Apoorva R. Vashi, M.D., Joseph E. Oesterling, M.D. 
Volume 50, Issue 5, Pages (November 2006)
Prostate Cancer 2008: Challenges in Diagnosis and Management
The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy  Neal Patel, Eliza Cricco-Lizza,
Volume 54, Issue 1, Pages (July 2008)
European Urology Oncology
Volume 54, Issue 3, Pages (September 2008)
European Urology Oncology
European Urology Oncology
Salvage Local Treatments After Focal Therapy for Prostate Cancer
European Urology Oncology
European Urology Oncology
Introduction European Urology Supplements
Assessing a Patient’s Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood  Jan F.M. Verbeek,
European Urology Oncology
Presentation transcript:

Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer  Armando Stabile, Paolo Dell’Oglio, Giorgio Gandaglia, Nicola Fossati, Giorgio Brembilla, Giulia Cristel, Federico Dehò, Vincenzo Scattoni, Tommaso Maga, Andrea Losa, Franco Gaboardi, Gianpiero Cardone, Antonio Esposito, Francesco De Cobelli, Alessandro Del Maschio, Francesco Montorsi, Alberto Briganti  European Urology Oncology  Volume 1, Issue 2, Pages 120-128 (June 2018) DOI: 10.1016/j.euo.2018.02.002 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 The operator learning curve for fusion biopsy. Probability of detecting clinically significant prostate cancer (PCa) after accounting for prostate-specific antigen, prostate volume, PI-RADS v.2 score, number of targeted cores per magnetic resonance imaging–detected lesion, digital rectal examination, and fusion biopsy approach (transrectal vs transperineal). PI-RADS=Prostate Imaging Recording and Data System. European Urology Oncology 2018 1, 120-128DOI: (10.1016/j.euo.2018.02.002) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 2 Learning curve for operator 1 (cognitive targeted biopsy). Probability of detecting clinically significant prostate cancer (PCa) after accounting for prostate-specific antigen, prostate volume, PI-RADS v.2 score, number of targeted cores per magnetic resonance imaging–detected lesion, and digital rectal examination. PI-RADS=Prostate Imaging Recording and Data System. European Urology Oncology 2018 1, 120-128DOI: (10.1016/j.euo.2018.02.002) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 3 Learning curve for operator 2 (transrectal fusion targeted biopsy). Probability of detecting clinically significant prostate cancer (PCa) after accounting for prostate-specific antigen, prostate volume, PI-RADS v.2 score, number of targeted cores per magnetic resonance imaging–detected lesion, and digital rectal examination. PI-RADS=Prostate Imaging Recording and Data System. European Urology Oncology 2018 1, 120-128DOI: (10.1016/j.euo.2018.02.002) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 4 Learning curve for operator 3 (transperineal fusion targeted biopsy). Probability of detecting clinically significant prostate cancer (PCa) after accounting for prostate-specific antigen, prostate volume, PI-RADS v.2 score, number of targeted cores per magnetic resonance imaging–detected lesion, and digital rectal examination. PI-RADS=Prostate Imaging Recording and Data System. European Urology Oncology 2018 1, 120-128DOI: (10.1016/j.euo.2018.02.002) Copyright © 2018 European Association of Urology Terms and Conditions